You are here: Industry Insights > DTC advertising

News List

What to do when an exposé tanks your stock? For J&J, you go direct to consumers fiercepharma
January 03, 2019
Johnson & Johnson is taking its baby powder case to consumers. A new print and online ad will begin running this week contending “Our talc is safe” and asking people to read the scientific evidence for themselves.
No peak in sight: Cancer marketing spreads across media landscape, from TV to digital fiercepharma
December 25, 2018
The move to mainstream cancer advertising began several years ago with Bristol-Myers Squibb’s big TV campaign for Opdivo, followed by competitor Merck & Co. for its rival, Keytruda.
Thank politicians—and maybe your doctor—as the drug price advertising debate drags on fiercepharma
December 25, 2018
Politicians on both sides of the aisle refuse to let go of the proposal to force pharma companies to add drug pricing to ads. But Washington insiders aren't solely to blame. Consumers and many physicians are quite keen on the idea, too.
No peak in sight: Cancer marketing spreads across media landscape, from TV to digital fiercepharma
December 20, 2018
The move to mainstream cancer advertising began several years ago with Bristol-Myers Squibb’s big TV campaign for Opdivo, followed by competitor Merck & Co. for its rival, Keytruda. Both put out broad and hopeful
Thank politicians—and maybe your doctor—as the drug price advertising debate drags on fiercepharma
December 20, 2018
Politicians on both sides of the aisle refuse to let go of the proposal to force pharma companies to add drug pricing to ads. But Washington insiders aren't solely to blame. Consumers and many physicians are quite keen on the idea, too.
What to do when an exposé tanks your stock? For J&J, you go direct to consumers fiercepharma
December 19, 2018
Johnson & Johnson is taking its baby powder case to consumers. A new print and online ad will begin running this week contending “Our talc is safe” and asking people to read the scientific evidence for themselves.
X marks the spot: Merz rolls new Xeomin brand push, awareness effort targeting 'Xennials' fiercepharma
December 11, 2018
The botulinum toxin drug market is tough to crack, especially for any treatment that doesn’t go by the name Botox.
Diabetes like me? Survey finds older people with diabetes want to see familiar families in ads fiercepharma
December 10, 2018
Older Americans with diabetes see advertising differently than their peers. That’s according to a new YouGov survey that found 39% of people with diabetes aged 50 and older want to see more ads with....
Trump's drug-prices-in-ads idea gets two more nay votes as federal comment deadline looms fiercepharma
December 05, 2018
In the latest salvos challenging the value of adding drug prices to pharma TV ads, two academics and a well-known advertising association have set out their arguments against the proposal.
Hip to headaches: GlaxoSmithKline's culture-savvy Excedrin rolls TV ads and custom boxes fiercepharma
September 13, 2018
Contemporary headache causes headlined Excedrin boxes last week, debuting at the same time as new TV and online ads.

Previous page 1 2 Next page